Oct 12, 2026 02:17AM
Oct 9, 2026 10:05AM
Oct 1, 2026 02:42AM
Sep 9, 2026 05:40AM
Sep 8, 2026 08:04AM
Aug 27, 2026 02:20AM
Aug 26, 2026 07:28AM Spyre (SYRE) Reiterated at Buy by Stifel on Topline Results From RA PoC Sub-Study
Aug 25, 2026 04:49PM
Aug 4, 2026 05:51PM
Jul 28, 2026 05:35AM
Jul 13, 2026 06:46AM
Jun 26, 2026 04:09PM
Jun 18, 2026 04:00PM
Jun 15, 2026 08:01AM Spyre reports positive phase 2 trial results for ulcerative colitis drug
Jun 4, 2026 04:10AM
Jun 3, 2026 08:03AM
May 5, 2026 04:26PM
May 5, 2026 10:20AM
Apr 13, 2026 04:21PM
Apr 13, 2026 03:10PM
Apr 13, 2026 02:39PM Syre Therapeutics (SYPR) PT Raised to $106 at Leerink Partners, 'initial SKYLINE results represent best-case data for SPY001'
Apr 13, 2026 12:37PM
Apr 13, 2026 11:24AM
Apr 13, 2026 10:38AM
Apr 13, 2026 08:45AM
Apr 13, 2026 08:26AM
Apr 13, 2026 08:21AM
Apr 13, 2026 07:57AM TD Cowen on Spyre (SYRE): 'we expect these data to further raise the ceiling for Spyre's future combos'
Apr 13, 2026 07:54AM
Apr 13, 2026 07:46AM
Apr 13, 2026 07:00AM
Apr 13, 2026 06:56AM
Mar 31, 2026 05:18AM
Mar 18, 2026 07:32AM
Mar 16, 2026 11:33AM Leerink Partners Reiterates Outperform Rating on Spyre (SYRE): 'today's update reflects SYRE's strong clinical execution'
Mar 16, 2026 10:39AM
Feb 19, 2026 04:35PM
Jan 12, 2026 08:04AM
Dec 17, 2025 04:04PM
Dec 17, 2025 05:02AM
Dec 1, 2025 12:33AM
Nov 5, 2025 07:29AM Spyre (SYRE) PT Lowered to $70 at Stifel
Nov 4, 2025 05:50PM
Oct 13, 2025 04:41PM
Oct 7, 2025 05:55AM
Sep 26, 2025 03:27AM
Aug 18, 2025 06:13AM
Aug 6, 2025 03:16AM
Jun 17, 2025 07:30AM Spyre Therapeutics (SYRE) Announces Positive Interim Phase 1 Results for Two Next-Generation TL1A Antibody Programs
Jun 4, 2025 06:23AM

479,029 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All